CSS
VIR icon

Cubist Systematic Strategies’s Vir Biotechnology VIR Stock Holding History

Cubist Systematic Strategies’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-119,985
Closed -$881K – 3577
2024
Q4 		$881K Sell
119,985
-54,755
-31% -$432K 0.01% 1872
2024
Q3 		$1.31M Sell
174,740
-13,884
-7% -$121K 0.01% 1669
2024
Q2 		$1.68M Buy
188,624
+185,723
+6,402% +$1.78M 0.01% 1445
2024
Q1 		$29.4K Sell
2,901
-210,288
-99% -$2.14M ﹤0.01% 3445
2023
Q4 		$2.14M Buy
213,189
+76,242
+56% +$697K 0.01% 1456
2023
Q3 		$1.28M Buy
+136,947
New +$1.95M 0.01% 1693
2023
Q2 		– Sell
-12,815
Closed -$298K – 4352
2023
Q1 		$298K Sell
12,815
-6,642
-34% -$170K ﹤0.01% 3000
2022
Q4 		$492K Sell
19,457
-86,050
-82% -$2.11M ﹤0.01% 3035
2022
Q3 		$2.03M Sell
105,507
-60,434
-36% -$1.54M 0.01% 1997
2022
Q2 		$4.23M Buy
165,941
+5,438
+3% +$127K 0.03% 1143
2022
Q1 		$4.13M Buy
160,503
+69,604
+77% +$2.06M 0.03% 877
2021
Q4 		$3.81M Buy
90,899
+85,035
+1,450% +$3.33M 0.04% 844
2021
Q3 		$255K Sell
5,864
-25,842
-82% -$1.12M ﹤0.01% 2448
2021
Q2 		$1.5M Buy
31,706
+15,605
+97% +$709K 0.02% 1286
2021
Q1 		$825K Buy
+16,101
New +$868K 0.01% 1655

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cubist Systematic Strategies's VIR Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Vir Biotechnology (VIR) in Q1 2025, closing a stake of 119,985 shares — an estimated $881K sold.

Cubist Systematic Strategies first reported a position in VIR in Q1 2021 and held it in 15 quarters. The position peaked at $4.23M in Q2 2022. 233 funds tracked by Wall St. Rank hold VIR as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Vir Biotechnology position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 119,985 Vir Biotechnology shares in Q1 2025, an estimated $881K.
  • Cubist Systematic Strategies first reported a position in Vir Biotechnology in Q1 2021 and held it in 15 quarters.
  • Cubist Systematic Strategies's Vir Biotechnology position peaked at $4.23M in Q2 2022.
  • 233 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.